Device Trial Radar · NCT01506401
The Oscillation for Acute Respiratory Distress Syndrome (ARDS) Treated Early (OSCILLATE) Trial
Last checked: Nov 20, 2026Latest source record: Aug 6, 2015 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
548
Actual
Start
Jun 2009
Primary completion
Sep 2012
Study completion Sep 2012
Sponsor
- Lead sponsor
- Canadian Critical Care Trials GroupAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Canadian Institutes of Health Research (CIHR); McMaster University; University of Toronto
- First posted
- Jan 10, 2012
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 16 years, up to 85 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
What is the effect of early high frequency oscillation (HFO) versus a lung-protective conventional ventilation (CV) strategy (using HFO only as rescue therapy), on all-cause hospital mortality among patients with severe early acute respiratory distress syndrome (ARDS)?
Conditions
- Acute Respiratory Distress Syndrome (ARDS)
Interventions
SensorMedics 3100B High Frequency Oscillatory VentilatorDevice
High Frequency Oscillation
Lung Protective VentilationProcedure
Tidal Volume 6ml/kg; plateau pressure \< or = 35cmH20; Prescribed PEEP/FiO2 chart
Primary outcomes
What the sponsor says the trial is designed to measure.
- All-cause hospital mortalityTime frame: Randomised patients will be ventilated according to their assigned ventilation strategy for up to 60 days, until they die on the ventilator or are successfully (for >24 hours) liberated from mechanical ventilation.
Locations
38 sites in 5 countries. Site status is shown where the registry gives one.
Denver Health Medical Centre
Denver, Colorado
Orlando Regional Medical Centre
Orlando, Florida
University of Michigan
Ann Arbor, Michigan
35 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.